• Simcere Pharmaceutical Group granted 795,000 RSUs under its 2021 RSU Scheme to eight employee participants.
• Awards carry nil purchase price; shares closed at HK$ 12.08 on the grant date.
• RSUs vest in three equal tranches on Aug. 21, 2027, 2028, 2029, subject to annual performance assessment.
• Grant will be satisfied using 795,000 trustee-held shares from previously lapsed RSUs.
• Shares available for future grants under the scheme mandate limit total 240,724,921 following the award.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260821-12294436), on August 21, 2026, and is solely responsible for the information contained therein.